285 related articles for article (PubMed ID: 9297136)
1. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
Pruna A; Barka A; Nochy D; Hauet T; Boulanger H; Landais P
Nephrologie; 1997; 18(3):95-101. PubMed ID: 9297136
[TBL] [Abstract][Full Text] [Related]
2. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
4. Pefloxacin in steroid dependent and resistant idiopathic nephrotic syndrome.
Sharma RK; Sahu KM; Gulati S; Gupta A
J Nephrol; 2000; 13(4):271-4. PubMed ID: 10946806
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
Al-Khader AA; Lien JW; Aber GM
Clin Nephrol; 1979 Jan; 11(1):26-30. PubMed ID: 428152
[TBL] [Abstract][Full Text] [Related]
6. [Pefloxacin as a treatment for nephrotic syndrome caused by minimal glomerular lesions in the adult: promises or deception?].
Moulin B
Nephrologie; 1997; 18(3):79-80. PubMed ID: 9297133
[No Abstract] [Full Text] [Related]
7. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
Matsumoto H; Nakao T; Okada T; Nagaoka Y; Shino T; Yoshino M; Hidaka H
Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
[TBL] [Abstract][Full Text] [Related]
8. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
Cade R; Mars D; Privette M; Thompson R; Croker B; Peterson J; Campbell K
Arch Intern Med; 1986 Apr; 146(4):737-41. PubMed ID: 3963956
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
12. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
16. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
Branten AJ; Wetzels JF
Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2832-8. PubMed ID: 10065257
[TBL] [Abstract][Full Text] [Related]
17. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
[TBL] [Abstract][Full Text] [Related]
18. Pefloxacin as first-line treatment in nephrotic syndrome.
Ginsburg C; Toledano D; Deray G; Vlassopoulos D; Baumelou A; Jacobs C
Nephrol Dial Transplant; 1994; 9(3):335. PubMed ID: 8052452
[No Abstract] [Full Text] [Related]
19. [Complete remission of steroid-resistant minimal-change nephrotic syndrome by cyclosporin after additional low-density lipoprotein apheresis treatment].
Okada T; Takahashi H; Ogura M; Nakao T; Shimizu T
Nihon Jinzo Gakkai Shi; 1996 Jan; 38(1):46-51. PubMed ID: 8855137
[TBL] [Abstract][Full Text] [Related]
20. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
García Donaire JA; Manzanera MI; Valentín MO; Espejo B; Gutiérrez Martínez E; Praga M
Nefrologia; 2004; 24(2):179-82. PubMed ID: 15219093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
